+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
FEMALE
ID06330870

Study of Brain Metastasis Development in Women with Breast Cancer Undergoing Brain Metastasis Surgery

Led by Samsung Medical Center · Updated on 2024-03-26

30

Participants Needed

1

Research Sites

151 weeks

Total Duration

AI-Summary

What this Trial Is About

Researchers are investigating how brain metastases develop in patients with breast cancer who have brain metastases. This study aims to understand the disease process by analyzing genetic and tumor environment factors in brain metastasis tissues. It is an experimental study led by Samsung Medical Center focusing specifically on breast cancer patients undergoing surgery for brain metastases. Participants undergo whole genome sequencing and tumor microenvironment evaluation using blood samples and brain metastasis tissue collected during curative brain metastasis surgery. This study does not include treatment interventions but focuses on analyzing specimens to gain insight into the mechanisms behind brain metastasis in breast cancer. During the study, participants brain metastasis tissue and blood are collected at the time of surgery for detailed genetic and tumor environment analysis. Researchers will measure intracranial disease-free survival in months as the primary outcome. The study involves no masking or randomization and follows participants over time to understand disease progression. The trial is designed for female patients undergoing curative surgery for brain metastasis from breast cancer.

CONDITIONS

Brief Title

Brain Metastasis Development Mechanism in BCBM Patients

Research Team

J

Ji-Yeon Kim

M

Mee Ryung Hong

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here